ATE109658T1 - Injizierbares arzneimittel. - Google Patents

Injizierbares arzneimittel.

Info

Publication number
ATE109658T1
ATE109658T1 AT91910762T AT91910762T ATE109658T1 AT E109658 T1 ATE109658 T1 AT E109658T1 AT 91910762 T AT91910762 T AT 91910762T AT 91910762 T AT91910762 T AT 91910762T AT E109658 T1 ATE109658 T1 AT E109658T1
Authority
AT
Austria
Prior art keywords
microspheres
formulations
contain
dia
microns
Prior art date
Application number
AT91910762T
Other languages
English (en)
Inventor
Garza Flores Josue
Soto Laura P Laiseca
Pichardo Jose Guillen
Uribe Juan Angeles
Original Assignee
Aplicaciones Farmaceuticas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aplicaciones Farmaceuticas filed Critical Aplicaciones Farmaceuticas
Application granted granted Critical
Publication of ATE109658T1 publication Critical patent/ATE109658T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT91910762T 1990-06-14 1991-06-12 Injizierbares arzneimittel. ATE109658T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9007416A FR2663223B1 (fr) 1990-06-14 1990-06-14 Forme galenique parenterale.

Publications (1)

Publication Number Publication Date
ATE109658T1 true ATE109658T1 (de) 1994-08-15

Family

ID=9397598

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91910762T ATE109658T1 (de) 1990-06-14 1991-06-12 Injizierbares arzneimittel.

Country Status (30)

Country Link
US (3) US5360616A (de)
EP (1) EP0533739B1 (de)
JP (1) JP2675675B2 (de)
KR (1) KR0157439B1 (de)
CN (1) CN1057442C (de)
AT (1) ATE109658T1 (de)
AU (1) AU661275B2 (de)
BG (1) BG61179B1 (de)
BR (1) BR9106545A (de)
CA (1) CA2085344C (de)
CZ (1) CZ286793B6 (de)
DE (1) DE69103419T2 (de)
DK (1) DK0533739T3 (de)
ES (1) ES2059142T3 (de)
FI (1) FI107698B (de)
FR (1) FR2663223B1 (de)
HU (1) HUT68709A (de)
IE (1) IE62679B1 (de)
IL (1) IL98459A (de)
NO (1) NO302998B1 (de)
NZ (1) NZ238542A (de)
PL (1) PL167234B1 (de)
PT (1) PT97975B (de)
RU (1) RU2104692C1 (de)
SK (1) SK280564B6 (de)
TN (1) TNSN91048A1 (de)
UA (1) UA27043C2 (de)
UY (1) UY23240A1 (de)
WO (1) WO1991019484A1 (de)
ZA (1) ZA914550B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
FR2732621B1 (fr) * 1995-04-10 1997-06-06 Rhone Poulenc Chimie Perles d'un produit presentant le phenomene de surfusion et leur procede d'obtention
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
DE69917000T2 (de) * 1998-02-25 2005-04-21 Abbott Lab Butorphanol enthaltende formulierungen mit verzögerter freisetzung
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
WO2001013885A1 (en) * 1999-08-20 2001-03-01 Norton Healthcare Ltd. Method to produce powders for pulmonary or nasal administration
US20070254009A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic/bone morphogenic protein formulation and method of treatment
US20070254008A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic formulation and method of treatment
US20030055075A1 (en) * 2001-07-13 2003-03-20 Rubsamen Reid M. Programmable controlled release injectable opioid formulation
GB0117696D0 (en) * 2001-07-20 2001-09-12 Bradford Particle Design Plc Particle information
PL1844765T3 (pl) * 2003-06-13 2015-06-30 Skendi Finance Ltd Formulacja estradiol-progesteron o spowolnionym uwalnianiu
US20050032811A1 (en) * 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
CA2537702C (en) 2003-09-03 2012-01-03 Miscon Trading S.A. Methods for the treatment of endometriosis
PT1684782E (pt) 2003-10-03 2015-12-21 Thorn Bioscience Llc Processo para a sincronização da ovulação para reprodução regulada sem detecção do cio
BRPI0415531B8 (pt) 2003-10-23 2021-05-25 Otsuka Pharma Co Ltd formulação de aripiprazol injetável estéril de liberação controlada e método para a sua preparação
US7413690B1 (en) 2003-10-29 2008-08-19 The University Of Mississippi Process and apparatus for producing spherical pellets using molten solid matrices
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
US7392635B2 (en) * 2005-06-09 2008-07-01 Tipper Tie, Inc. Breech loader packaging systems and associated breech loading chutes and methods
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
EP2078052B1 (de) 2006-10-31 2010-07-28 Surmodics Pharmaceuticals, Inc. Kugelförmige polymer-teilchen
CA2695178C (en) 2007-07-31 2015-06-23 Otsuka Pharmaceutical Co., Ltd. Methods for producing aripiprazole suspension and freeze-dried formulation
CA2721509A1 (en) * 2008-04-14 2009-10-22 Posi Visionary Solutions Llp Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications
CN102596215B (zh) 2009-04-23 2015-04-29 佩纳特克有限责任公司 用于同步授精时间的方法和组合物
UY33103A (es) 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
WO2014085674A1 (en) 2012-11-28 2014-06-05 Jbs United Animal Health Ii Llc Method for synchronizing time of insemination in gilts
WO2017105512A1 (en) 2015-12-18 2017-06-22 Proinvet Innovations S.A. Formulations and methods for controlling the reproductive cycle and ovulation
JP2019506443A (ja) * 2016-02-24 2019-03-07 イースタン バージニア メディカル スクール 改良された持効性注射用デポ型ブタン酸レボノルゲストレル懸濁製剤
CN106063783B (zh) * 2016-06-16 2019-03-12 浙江爱生药业有限公司 一种黄体酮缓释微囊制剂及其制备方法
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
CN115212170B (zh) * 2021-04-19 2024-01-26 中国人民解放军军事科学院军事医学研究院 一种致密圆整的药物球形微晶及其制备方法和其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670438A (de) * 1964-10-06 1966-01-31
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3928566A (en) * 1970-08-14 1975-12-23 Du Pont Lyophilized biological products
JPS5017525A (de) * 1973-06-14 1975-02-24
CA1077842A (en) * 1975-10-09 1980-05-20 Minnesota Mining And Manufacturing Company Albumin medicament carrier system
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
US4349580A (en) * 1978-08-18 1982-09-14 Queen's University At Kingston Process and solution for preserving green plant tissues
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
IL79407A (en) * 1985-08-01 1991-03-10 Theragenics Corp System and method for delivering insoluble material into a living body
EP0257368B1 (de) * 1986-08-11 1992-03-25 American Cyanamid Company Zusammensetzungen zur parenteralen Verabreichung und deren Verwendung
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
ATE109941T1 (de) * 1987-04-06 1994-09-15 Endocon Inc Durch schnellschmelzen hergestellte medizinische implantate.
US4892734A (en) * 1987-04-06 1990-01-09 Endocon, Inc. Dispensing paste for forming medicinal pellets
US4748024A (en) * 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
DE69005800T2 (de) * 1989-05-01 1994-05-19 Alkermes Inc Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekülen.

Also Published As

Publication number Publication date
BG61179B1 (bg) 1997-02-28
CN1057442C (zh) 2000-10-18
IE62679B1 (en) 1995-02-22
DK0533739T3 (da) 1995-01-09
CA2085344A1 (en) 1991-12-15
ZA914550B (en) 1992-03-25
PL290677A1 (en) 1992-11-30
CN1057961A (zh) 1992-01-22
PL167234B1 (pl) 1995-08-31
UY23240A1 (es) 1991-07-12
HUT68709A (en) 1995-07-28
NO924792L (no) 1993-02-03
NZ238542A (en) 1993-09-27
FR2663223A1 (fr) 1991-12-20
RU2104692C1 (ru) 1998-02-20
DE69103419D1 (de) 1994-09-15
BG97166A (bg) 1993-12-24
KR0157439B1 (ko) 1998-11-16
NO924792D0 (no) 1992-12-11
CA2085344C (en) 1998-06-30
FR2663223B1 (fr) 1994-12-02
AU8084791A (en) 1992-01-07
JP2675675B2 (ja) 1997-11-12
CZ286793B6 (cs) 2000-07-12
FI925661A0 (fi) 1992-12-11
NO302998B1 (no) 1998-05-18
CS181691A3 (en) 1992-06-17
AU661275B2 (en) 1995-07-20
BR9106545A (pt) 1993-06-01
EP0533739B1 (de) 1994-08-10
US5633014A (en) 1997-05-27
SK280564B6 (sk) 2000-03-13
US5360616A (en) 1994-11-01
PT97975A (pt) 1992-04-30
PT97975B (pt) 1998-11-30
FI925661A (fi) 1992-12-11
IL98459A0 (en) 1992-07-15
FI107698B (fi) 2001-09-28
ES2059142T3 (es) 1994-11-01
HU9203958D0 (en) 1993-03-29
TNSN91048A1 (fr) 1992-10-25
UA27043C2 (uk) 2000-02-28
IL98459A (en) 1996-09-12
IE912017A1 (en) 1991-12-18
JPH05507694A (ja) 1993-11-04
EP0533739A1 (de) 1993-03-31
DE69103419T2 (de) 1995-03-30
US5512303A (en) 1996-04-30
WO1991019484A1 (fr) 1991-12-26

Similar Documents

Publication Publication Date Title
ATE109658T1 (de) Injizierbares arzneimittel.
IL170181A (en) (4r) and (4s)-diastereoisomers of (2s)-2-[oxy-4-propylpyrrolidinyl]butanamide, pharmaceutical compositions comprising them and their use for preparing medicaments
EP0857081A4 (de) Herstellung von peptidhältigen, biologisch abbaubaren mikrokügelchen durch ein schmelzverfahren
DK0744941T3 (da) Fremgangsmåde til fremstilling af findelte farmaceutiske formuleringer
FI945465A0 (fi) Menetelmä hidastetusti vapauttavien lääkevalmisteiden valmistamiseksi
CA2275479A1 (en) Prevention of loss and restoration of bone mass by certain prostaglandin agonists
HRP20040033B1 (en) Dry powder inhalation system for transpulmonary administration
DZ2303A1 (fr) Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
EP0235603A3 (de) Verfahren zum Herstellen gleichförmiger Tröpfchen
YU48766B (sh) Postupak za dobijanje farmaceutskog preparata za oralnu primenu sa usporenim oslobađanjem aktivne supstance bez rastvarača
IS2036B (is) Lyfjablanda á formi dropalausnar sem inniheldur skammvirkt kalsíummótlyf af tvíhýdrópýridíngerð semvinna gegn háþrýstingi
MY110585A (en) Isothermal preparation of chocolate products
DE59812736D1 (de) Verfahren zur herstellung von regulären porösen perlcellulosen
DK0482183T3 (da) Histamin-H3-receptoragonistforbindelser til terapeutisk anvendelse, farmaceutiske sammensætninger virkende som agonister for nævnte receptor og fremstillingsmetode
BR9611320B1 (pt) composição farmacêutica compreendendo bidarit, um imunossurpressor selecionado a partir de ciclofosfamida, metilprednisolona, prednisolona e prednisona.
MA26437A1 (fr) Derives de trans-piperazine-1-yl-spiro (cyclohexane-1,1'-isobenzofuranne), procede pour leur preparation et compositions pharmaceutiques les contenant.
ES2185776T3 (es) Composicion farmaceutica preparada por adicion de un vehiculo aromatizante a un medicamento.
AU1381401A (en) Method and device for producing powders that consist of substantially spherical particles
FR2705570B1 (fr) Nouvelle formulation d'aérosol médicamentaux à base de fusafungine, son procédé de préparation et les compositions pharmaceutiques qui la contiennent.
BE901254A (fr) Formulations pharmaceutiques et veterinaires.
EP0180754A3 (de) 3,4-Diazolderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CA2250115A1 (en) Fast disintegrating oral dosage form
JPS55129152A (en) Production of inogranic composition and cyclohexane derivative using it
SV1998000062A (es) Formulaciones farmaceuticas y otras ref. jab 865

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee